NCT07395687: A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- State
- Under way
- Phase
- Phase 2
- People
- 333 planned
- Started
- 2 Feb 2026
- Primary completion
- 14 Jan 2027
- Arms
- Part A - UBT251, Part B - Arm A (UBT251), Part B - Arm B (UBT251), Part B - Arm C (UBT251), Part B - Arm D (UBT251), Part B - Arm E (UBT251), Part C - UBT251 dose 1, Part C - UBT251 dose 2, Part C - UBT251 dose 3
- Results
- None posted
- 2 Feb 2026: Trial started
- 9 Feb 2026: Trial registered